Family Medicine

Five-year data from the ENDORSE study shows that patients with multiple sclerosis who continued treatment, or who switched from another medication, experienced improved NEDA outcomes.

Mikkel Anthonisan, MD, highlights his experience as the founder of Oceans of Hope, a global voyage to change the perception of multiple sclerosis, at the 2014 Joint ACTRIMS-ECTRIMS Meeting.

Treatment with alemtuzumab was associated with reduced relapse rates and improved MRI outcomes compared to treatment with subcutaneous interferon beta-1a.

Novel drug shown to be more effective than interferon beta-1a in the treatment of multiple sclerosis, but concerns remain over hepatotoxicity, cutaneous reactions, and other adverse events associated with treatment.

A series of nurse-led interventions and patient education, along with titrated drug initiation, were the key components of a successful initiation protocol for patients with multiple sclerosis starting therapy on dimethyl fumarate. The new protocol resulted in fewer discontinuations than the standard initiation protocol.

Medication commonly used to reduce cholesterol could also be used to help patients with diabetes reduce their risk of serious complications like blindness and amputations.

People who smoke and have more sodium in their diets than others could also be more likely to eventually develop rheumatoid arthritis (RA), according to a recent study.

The US Food and Drug Administration recently approved a new algorithm that will enable many smart phones to detect signs of atrial fibrillation.

As the Ebola outbreak in West Africa continues to intensify and widen, the collection of obstacles in the way of the people trying to help those so desperately in need also seems to constantly be growing.

Contrave (naltrexone hydrochloride and bupropion hydrochloride extended-release tablets) is a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity.

Researchers at Wake Forest Baptist Medical Center recently announced a breakthrough in the development of a replacement kidney.

Breast feeding can potentially protect premature babies from a toxic gastrointestinal disease, according to a recent study published in in the American Journal of Pathology.

Investigators have found that many autoimmune diseases are implicated in the surge and development of eating disorders, according to a study published in PLoS One.

Vaccination coverage among US children ages 19 to 35 months in 2013 increased relative to 2012 data from the National Immunization Survey for some vaccines (rotavirus, Hep B birth dose, and ≥ 1HepA dose).

The Ebola outbreak in West Africa is showing no signs of slowing down. As more people become infected and die from the virus, the World Health Organization (WHO) is looking for international help to bring the medical emergency under control.

The makeup of a person's brain chemistry could play a role in their environmental food cues, according to the results of a new study.

The first accurate measurements of ideal growth and developments from conception to birth depicting a healthy pattern of growth desirable for all fetuses and newborns regardless of ethnic origin have been published in The Lancet.

Staff scientists at the US Food and Drug Administration (FDA) have concluded that there's no "convincing evidence" linking testosterone replacement therapy with adverse cardiovascular events.

A new study showing significant negative correlation between phthalate absorption and testosterone levels adds considerably more weight and significant new details to a growing body of research.

The most devastating outbreak of the Ebola virus to date continues to take the lives of more people in West Africa, leaving the rest of the world to figure out not only how to prevent future outbreaks but also what may have caused this one.

When autoimmune diseases like multiple sclerosis attack a patient's body from the inside it can be a difficult reminder of how hard it can be to treat a condition from the inside out.

A new test recently approved by the US Food and Drug Administration could go a long way in helping identify patients who could suffer acute kidney injury following hospitalization.

With the World Health Organization reporting that more than 2,000 people have died during the Ebola virus outbreak in West Africa, researchers are urgently testing several experimental treatments in hopes of developing effective remedies against the deadly virus. One such potential treatment is currently being tested on monkeys by researchers from the US National Institutes of Health and GlaxoSmithKline.

Drug formerly known as Zerenex gets approval following Phase 3 clinical trials

A new study published in the Journal of Clinical Pharmacology suggests poor stomach absorption could potentially decrease the efficacy of autism drugs.

A research team with members at the University of California, Los Angeles (UCLA) has discovered genetic factors involved in a severe form of inflammatory bowel disease (IBS), pediatric ulcerative colitis.

While high school seniors' marijuana use was linked to issues with authority, their alcohol consumption resulted in unsafe driving practices and strained peer relationships.

The race to approve the first drug to treat the Ebola virus got a new entrant recently when Johnson & Johnson (J&J) announced it would "fast-track" the development of a new vaccine.

Patients with osteoporosis have to deal with many potential complications and comorbidities with their condition, most notably the risk of fracture as a result of the bone loss.

Until apremilast was approved earlier this year, patients with psoriatic arthritis had to rely primarily on injectable therapies, which contributed to less than optimal treatment adherence in many patients.